Neurotoxicity Syndromes

"Neurotoxicity Syndromes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Neurologic disorders caused by exposure to toxic substances through ingestion, injection, cutaneous application, or other method. This includes conditions caused by biologic, chemical, and pharmaceutical agents.

Descriptor ID	D020258
MeSH Number(s)	C10.720 C25.723.705
Concept/Terms	Neurotoxicity Syndromes Neurotoxicity Syndromes Neurotoxicity Syndrome Syndrome, Neurotoxicity Syndromes, Neurotoxicity Neurotoxin Disorders Neurotoxin Disorder Neurotoxic Disorders Neurotoxic Disorder Neurotoxin Diseases Neurotoxin Disease Poisoning, Nervous System Nervous System Poisonings Poisonings, Nervous System Nervous System Poisoning Encephalopathy, Toxic Encephalopathy, Toxic Encephalopathies, Toxic Toxic Encephalopathies Toxic Encephalopathy Toxic Encephalitis Toxic Encephalitis Encephalitides, Toxic Encephalitis, Toxic Toxic Encephalitides

Below are MeSH descriptors whose meaning is more general than "Neurotoxicity Syndromes".

Diseases [C]
Nervous System Diseases [C10]
Neurotoxicity Syndromes [C10.720]
Chemically-Induced Disorders [C25]
Poisoning [C25.723]
Neurotoxicity Syndromes [C25.723.705]

Below are MeSH descriptors whose meaning is related to "Neurotoxicity Syndromes".

Below are MeSH descriptors whose meaning is more specific than "Neurotoxicity Syndromes".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Neurotoxicity Syndromes" by people in this website by year, and whether "Neurotoxicity Syndromes" was a major or minor topic of these publications.

Bar chart showing 18 publications over 11 distinct years, with a maximum of 4 publications in 2011

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
2000	0	1	1
2006	1	0	1
2007	1	0	1
2009	0	2	2
2011	3	1	4
2012	1	0	1
2018	2	1	3
2020	2	0	2
2021	0	1	1
2023	1	0	1
2024	0	1	1

Below are the most recent publications written about "Neurotoxicity Syndromes" by people in Profiles.

Diorio C, Hernandez-Miyares L, Espinoza DA, Banwell BL, Bar-Or A, DiNofia AM, Barz Leahy A, Martinez Z, Myers RM, Hopkins SE, Rheingold SR, Teachey DT, Viaene AN, Wray LM, Maude SL, Grupp SA, McGuire JL. Quadriparesis and paraparesis following chimeric antigen receptor T-cell therapy in children and adolescents. Blood. 2024 09 26; 144(13):1387-1398.

View in: PubMed
Schneider JS. Neurotoxicity and Outcomes from Developmental Lead Exposure: Persistent or Permanent? Environ Health Perspect. 2023 08; 131(8):85002.

View in: PubMed
Banerjee R, Shah N, Dicker AP. Next-Generation Implementation of Chimeric Antigen Receptor T-Cell Therapy Using Digital Health. JCO Clin Cancer Inform. 2021 06; 5:668-678.

View in: PubMed
Rusmini P, Cristofani R, Tedesco B, Ferrari V, Messi E, Piccolella M, Casarotto E, Chierichetti M, Cicardi ME, Galbiati M, Geroni C, Lombardi P, Crippa V, Poletti A. Enhanced Clearance of Neurotoxic Misfolded Proteins by the Natural Compound Berberine and Its Derivatives. Int J Mol Sci. 2020 May 13; 21(10).

View in: PubMed
Mack AH, Schofield HL. Applying (or Not?) CAR-T Neurotoxicity Experience to COVID-19 Delirium and Agitation. Psychosomatics. 2020 Nov-Dec; 61(6):859-860.

View in: PubMed
Chen-Roetling J, Regan KA, Regan RF. Protective effect of vitreous against hemoglobin neurotoxicity. Biochem Biophys Res Commun. 2018 09 03; 503(1):152-156.

View in: PubMed
Balderia PG, Chandorkar A, Kim Y, Patnaik S, Sloan J, Newman GC. Dosing Cefepime for Renal Function Does Not Completely Prevent Neurotoxicity in a Patient With Kidney Transplant. J Patient Saf. 2018 06; 14(2):e33-e34.

View in: PubMed
Chen-Roetling J, Ma SK, Cao Y, Shah A, Regan RF. Hemopexin increases the neurotoxicity of hemoglobin when haptoglobin is absent. J Neurochem. 2018 06; 145(6):464-473.

View in: PubMed
Sugihara K, Ohtsu A, Shimada Y, Mizunuma N, Gomi K, Lee PH, Gramont A, Rothenberg ML, Andr? T, Brienza S, Goldberg RM. Analysis of neurosensory adverse events induced by FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studies. Cancer Med. 2012 Oct; 1(2):198-206.

View in: PubMed
Sugihara K, Ohtsu A, Shimada Y, Mizunuma N, Lee PH, de Gramont A, Goldberg RM, Rothenberg ML, Andr? T, Brienza S, Gomi K. Safety analysis of FOLFOX4 treatment in colorectal cancer patients: a comparison between two Asian studies and four Western studies. Clin Colorectal Cancer. 2012 Jun; 11(2):127-37.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement